S&P 500   4,140.06 (-0.12%)
DOW   32,832.54 (+0.09%)
QQQ   320.71 (-0.32%)
AAPL   164.87 (-0.29%)
MSFT   280.32 (-0.92%)
META   170.25 (+1.88%)
GOOGL   117.30 (-0.14%)
AMZN   139.41 (-0.99%)
TSLA   871.27 (+0.78%)
NVDA   177.93 (-6.30%)
NIO   20.17 (-0.25%)
BABA   90.84 (-1.86%)
AMD   100.07 (-2.19%)
MU   61.45 (-1.62%)
T   18.00 (-1.91%)
CGC   3.28 (+21.48%)
GE   75.18 (+1.10%)
F   15.78 (+3.14%)
DIS   109.11 (+2.33%)
AMC   23.96 (+8.03%)
PYPL   96.26 (+0.99%)
PFE   49.57 (+0.61%)
NFLX   233.49 (+2.96%)
S&P 500   4,140.06 (-0.12%)
DOW   32,832.54 (+0.09%)
QQQ   320.71 (-0.32%)
AAPL   164.87 (-0.29%)
MSFT   280.32 (-0.92%)
META   170.25 (+1.88%)
GOOGL   117.30 (-0.14%)
AMZN   139.41 (-0.99%)
TSLA   871.27 (+0.78%)
NVDA   177.93 (-6.30%)
NIO   20.17 (-0.25%)
BABA   90.84 (-1.86%)
AMD   100.07 (-2.19%)
MU   61.45 (-1.62%)
T   18.00 (-1.91%)
CGC   3.28 (+21.48%)
GE   75.18 (+1.10%)
F   15.78 (+3.14%)
DIS   109.11 (+2.33%)
AMC   23.96 (+8.03%)
PYPL   96.26 (+0.99%)
PFE   49.57 (+0.61%)
NFLX   233.49 (+2.96%)
S&P 500   4,140.06 (-0.12%)
DOW   32,832.54 (+0.09%)
QQQ   320.71 (-0.32%)
AAPL   164.87 (-0.29%)
MSFT   280.32 (-0.92%)
META   170.25 (+1.88%)
GOOGL   117.30 (-0.14%)
AMZN   139.41 (-0.99%)
TSLA   871.27 (+0.78%)
NVDA   177.93 (-6.30%)
NIO   20.17 (-0.25%)
BABA   90.84 (-1.86%)
AMD   100.07 (-2.19%)
MU   61.45 (-1.62%)
T   18.00 (-1.91%)
CGC   3.28 (+21.48%)
GE   75.18 (+1.10%)
F   15.78 (+3.14%)
DIS   109.11 (+2.33%)
AMC   23.96 (+8.03%)
PYPL   96.26 (+0.99%)
PFE   49.57 (+0.61%)
NFLX   233.49 (+2.96%)
S&P 500   4,140.06 (-0.12%)
DOW   32,832.54 (+0.09%)
QQQ   320.71 (-0.32%)
AAPL   164.87 (-0.29%)
MSFT   280.32 (-0.92%)
META   170.25 (+1.88%)
GOOGL   117.30 (-0.14%)
AMZN   139.41 (-0.99%)
TSLA   871.27 (+0.78%)
NVDA   177.93 (-6.30%)
NIO   20.17 (-0.25%)
BABA   90.84 (-1.86%)
AMD   100.07 (-2.19%)
MU   61.45 (-1.62%)
T   18.00 (-1.91%)
CGC   3.28 (+21.48%)
GE   75.18 (+1.10%)
F   15.78 (+3.14%)
DIS   109.11 (+2.33%)
AMC   23.96 (+8.03%)
PYPL   96.26 (+0.99%)
PFE   49.57 (+0.61%)
NFLX   233.49 (+2.96%)
NASDAQ:NXGN

NextGen Healthcare - NXGN Stock Forecast, Price & News

$17.29
-0.20 (-1.14%)
(As of 08/8/2022 12:00 AM ET)
Add
Compare
Today's Range
$17.22
$17.59
50-Day Range
$16.28
$18.71
52-Week Range
$13.64
$21.87
Volume
296,432 shs
Average Volume
383,011 shs
Market Capitalization
$1.18 billion
P/E Ratio
1,730.73
Dividend Yield
N/A
Price Target
$24.00

NextGen Healthcare MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
38.7% Upside
$24.00 Price Target
Short Interest
Healthy
1.85% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.00mentions of NextGen Healthcare in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$185,185 Sold Last Quarter
Proj. Earnings Growth
14.52%
From $0.62 to $0.71 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.30 out of 5 stars

Medical Sector

335th out of 1,293 stocks

Computer Integrated Systems Design Industry

14th out of 44 stocks

NXGN stock logo

About NextGen Healthcare (NASDAQ:NXGN) Stock

NextGen Healthcare, Inc. provides healthcare technology solutions in the United States. The company offers clinical care solutions, including NextGen Enterprise EHR; financial solutions, such as NextGen Enterprise PM; patient engagement solutions comprising NextGen Virtual Visits; integrated clinical care and financial solutions consisting of NextGen Office; interoperability solutions that include NextGen Share and Mirth Connect; data and analytics solutions, which comprise NextGen Health Data Hub; and value based care solutions, including NextGen Population Health Solutions. It also provides managed services, such as revenue cycle management services comprising billing and collections, electronic claims submission and denials management, electronic remittance and payment posting, and accounts receivable follow-up; and client and support services. Further, the company offers professional services consisting of training, project management, installation services, and application managed services; and consulting services that include physician, professional, and technical consulting; assisting clients to optimize their staffing and software solutions; enhancing financial and clinical outcomes; achieving regulatory requirements; and meeting the requirements of healthcare reform. It serves accountable care organizations, independent physician associations, managed service organizations, veterans service organizations, dental service organizations, ambulatory care centers, and community health centers through a direct sales force and reseller channel. The company was formerly known as Quality Systems, Inc. and changed its name to NextGen Healthcare, Inc. in September 2018. NextGen Healthcare, Inc. was incorporated in 1974 and is headquartered in Atlanta, Georgia.

Analyst Ratings Changes

Separately, Guggenheim raised NextGen Healthcare from a "neutral" rating to a "buy" rating and set a $26.00 price objective on the stock in a report on Friday, May 6th.

NextGen Healthcare Stock Performance

Shares of NASDAQ:NXGN traded down $0.20 during trading on Monday, reaching $17.29. The stock had a trading volume of 296,432 shares, compared to its average volume of 383,011. The business has a fifty day moving average price of $17.58 and a 200-day moving average price of $18.90. The stock has a market cap of $1.18 billion, a PE ratio of 1,750.75 and a beta of 1.07. NextGen Healthcare has a 1-year low of $13.64 and a 1-year high of $21.87.

NextGen Healthcare (NASDAQ:NXGN - Get Rating) last issued its quarterly earnings results on Tuesday, May 17th. The company reported $0.10 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.10. NextGen Healthcare had a positive return on equity of 8.20% and a negative net margin of 0.01%. The firm had revenue of $151.26 million for the quarter, compared to analyst estimates of $150.07 million. During the same period in the previous year, the company posted $0.13 earnings per share. The business's revenue was up 4.9% on a year-over-year basis. Sell-side analysts expect that NextGen Healthcare will post 0.62 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Craig A. Barbarosh sold 3,500 shares of NextGen Healthcare stock in a transaction that occurred on Friday, July 1st. The stock was sold at an average price of $17.39, for a total transaction of $60,865.00. Following the transaction, the director now owns 64,183 shares in the company, valued at $1,116,142.37. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Over the last 90 days, insiders have sold 10,500 shares of company stock worth $185,185. 4.50% of the stock is owned by corporate insiders.

Receive NXGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NextGen Healthcare and its competitors with MarketBeat's FREE daily newsletter.

NXGN Stock News Headlines

NextGen Needs To Live Up To Its Name
See More Headlines
Receive NXGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NextGen Healthcare and its competitors with MarketBeat's FREE daily newsletter.

NXGN Company Calendar

Last Earnings
5/17/2022
Today
8/08/2022
Next Earnings (Estimated)
10/27/2022
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Computer integrated systems design
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NXGN
Employees
2,655
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$24.00
High Stock Price Forecast
$26.00
Low Stock Price Forecast
$22.00
Forecasted Upside/Downside
+38.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$1.62 million
Pretax Margin
0.45%

Debt

Sales & Book Value

Annual Sales
$596.35 million
Cash Flow
$1.31 per share
Book Value
$6.33 per share

Miscellaneous

Free Float
64,958,000
Market Cap
$1.18 billion
Optionable
Optionable
Beta
1.07














NXGN Stock - Frequently Asked Questions

Should I buy or sell NextGen Healthcare stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for NextGen Healthcare in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NXGN shares.
View NXGN analyst ratings
or view top-rated stocks.

What is NextGen Healthcare's stock price forecast for 2022?

2 Wall Street research analysts have issued 12 month target prices for NextGen Healthcare's shares. Their NXGN stock forecasts range from $22.00 to $26.00. On average, they predict the company's share price to reach $24.00 in the next twelve months. This suggests a possible upside of 38.7% from the stock's current price.
View analysts price targets for NXGN
or view top-rated stocks among Wall Street analysts.

How has NextGen Healthcare's stock price performed in 2022?

NextGen Healthcare's stock was trading at $17.79 on January 1st, 2022. Since then, NXGN shares have decreased by 2.8% and is now trading at $17.30.
View the best growth stocks for 2022 here
.

When is NextGen Healthcare's next earnings date?

NextGen Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our NXGN earnings forecast
.

How were NextGen Healthcare's earnings last quarter?

NextGen Healthcare, Inc. (NASDAQ:NXGN) posted its earnings results on Tuesday, May, 17th. The company reported $0.10 EPS for the quarter, hitting analysts' consensus estimates of $0.10. The firm earned $151.26 million during the quarter, compared to analyst estimates of $150.07 million. NextGen Healthcare had a positive trailing twelve-month return on equity of 8.20% and a negative net margin of 0.01%. The firm's revenue was up 4.9% compared to the same quarter last year. During the same period last year, the firm posted $0.13 earnings per share.

What guidance has NextGen Healthcare issued on next quarter's earnings?

NextGen Healthcare issued an update on its FY 2023 earnings guidance on Thursday, August, 4th. The company provided EPS guidance of $0.92-$0.98 for the period, compared to the consensus EPS estimate of $0.98. The company issued revenue guidance of $621.00 million-$633.00 million, compared to the consensus revenue estimate of $634.04 million.

What is Rusty Frantz's approval rating as NextGen Healthcare's CEO?

248 employees have rated NextGen Healthcare Chief Executive Officer Rusty Frantz on Glassdoor.com. Rusty Frantz has an approval rating of 72% among the company's employees.

What other stocks do shareholders of NextGen Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NextGen Healthcare investors own include Altria Group (MO), Verizon Communications (VZ), Exxon Mobil (XOM), Best Buy (BBY), Enbridge (ENB), Enterprise Products Partners (EPD), Huntington Bancshares (HBAN), Netflix (NFLX), Tapestry (TPR) and Twitter (TWTR).

What is NextGen Healthcare's stock symbol?

NextGen Healthcare trades on the NASDAQ under the ticker symbol "NXGN."

Who are NextGen Healthcare's major shareholders?

NextGen Healthcare's stock is owned by many different institutional and retail investors. Top institutional shareholders include Smith Graham & Co. Investment Advisors LP (1.00%), Assenagon Asset Management S.A. (0.74%), Seizert Capital Partners LLC (0.35%), State Board of Administration of Florida Retirement System (0.21%), New York State Teachers Retirement System (0.19%) and Russell Investments Group Ltd. (0.18%). Insiders that own company stock include Craig A Barbarosh, David A Metcalfe, David Ahmadzai, David William Sides, Donna Cullen Greene, George H Bristol, James Robert Jr Arnold, Jeffrey D Linton, Jeffrey H Margolis, John R Frantz, Lance Rosenzweig, Mitchell Waters, Sean Brynjelsen and Srinivas S Velamoor.
View institutional ownership trends
.

How do I buy shares of NextGen Healthcare?

Shares of NXGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NextGen Healthcare's stock price today?

One share of NXGN stock can currently be purchased for approximately $17.30.

How much money does NextGen Healthcare make?

NextGen Healthcare (NASDAQ:NXGN) has a market capitalization of $1.18 billion and generates $596.35 million in revenue each year. The company earns $1.62 million in net income (profit) each year or $0.01 on an earnings per share basis.

How many employees does NextGen Healthcare have?

NextGen Healthcare employs 2,655 workers across the globe.

How can I contact NextGen Healthcare?

NextGen Healthcare's mailing address is 18111 Von Karman Avenue Suite 800, Irvine CA, 92612. The official website for the company is www.nextgen.com. The company can be reached via phone at (404) 467-1500, via email at ir@nextgen.com, or via fax at 949-255-2605.

This page (NASDAQ:NXGN) was last updated on 8/8/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.